BCAL Diagnostics (ASX:BDX) Other Stockholders Equity: A$-0.00 Mil (As of Dec. 2025)


What is BCAL Diagnostics Other Stockholders Equity?

BCAL Diagnostics ASX:BDX +1.41% Other Stockholders Equity is A$-0.00 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

BCAL Diagnostics's Other Stockholders Equity for the quarter that ended in Dec. 2025 was A$-0.00 Mil.

BCAL Diagnostics's quarterly Other Stockholders Equity declined from Dec. 2024 (A$-0.00 Mil) to Jun. 2025 (A$-0.00 Mil) but then increased from Jun. 2025 (A$-0.00 Mil) to Dec. 2025 (A$-0.00 Mil).

BCAL Diagnostics's annual Other Stockholders Equity declined from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$-0.00 Mil) and declined from Jun. 2024 (A$-0.00 Mil) to Jun. 2025 (A$-0.00 Mil).

BCAL Diagnostics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Other Stockholders Equity Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
0.00 0.00 -0.00 -0.00

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 -0.00

BCAL Diagnostics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of A$-0.00 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Other Stockholders Equity of A$-0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Other Stockholders Equity too high?
BCAL Diagnostics' current Other Stockholders Equity is A$-0.00 Mil.
How does BCAL Diagnostics' Other Stockholders Equity compare to TMO and DHR?
BCAL Diagnostics' Other Stockholders Equity of A$-0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Other Stockholders Equity is A$-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Other Stockholders Equity of A$-0.00 Mil. The current Other Stockholders Equity is A$-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Other Stockholders Equity is A$-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.